QUIPMENT
Acquired by
SAGARD
QUIPMENT acquired by SAGARD
Target
QUIPMENT
Acquirer
SAGARD
Context
Sagard NewGen acquired a significant minority stake in Quipment, fifteen years after its inception. The deal aims to accelerate Quipment's international expansion, particularly in the US and Asia, and to support its digital transformation. This transaction follows a similar move in the sector by Antin IP with Emsere.
This transaction is part of the Healthcare & Pharma industry, which currently tracks an average EBITDA multiple of 13.4x since the beginning of 2026, 1.2% decrease compared to 2025. This data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.
-> Deep-dive in Healthcare & Pharma market trends
Target
A specialized provider of medical equipment and clinical trial logistics services. Quipment offers global solutions for the sourcing, rental, and maintenance of medical devices used in clinical trials, ensuring compliance and operational efficiency for pharmaceutical companies and CROs worldwide.
Ent. Value
LOGIN
Equity Value
LOGIN
Multiples Analysis
EV / Revenue
LOGIN
EV / EBITDA
LOGIN
EV / EBIT
LOGIN
Historical Financials (EUR)
Other operations with QUIPMENT
mynth data is contributed by M&A / PE professionals and systematically cross-verified against private deal documents and official releases. All source materials are destroyed post-validation to guarantee data anonymity and compliance.